Delivery Order SPE2DB22D2206-SPE2DB25FFV36

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,684.96 and a period of performance through January 7, 2025. The contract is not designated as a set-aside....
This federal contract award, valued at $7,744.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication, to support military healthcare programs. This is a Firm Fixed Price delivery order contract with a completion date of February 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $56,313.92, is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,707.25, is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a performance period extending to January 17, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, valued at $14,774.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,676.76 delivery order contract is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML medical products. The contract has a ceiling value of $6,686.48 and is a Firm Fixed Price Delivery Order running through September 2023. The award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $7,154.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of STELARA 90 MG/ML syringes, a specialty medication. The contract has an ultimate completion date of November 15, 2024 and is a firm fixed-price type. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award, valued at $22,466.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999, which AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $7,448.52 for the procurement of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of January 31, 2025 and utilizes a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFV36
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication, to support military healthcare programs. The contract has a ceiling value of $7,608.43 and runs through February 26, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 5/27/25, 9:54 AM